[Analysis of the HIV antibody screening results among the preoperative examination patients in Beijing Tongren Hospital from 2008 to 2018].

Objective: To understand the HIV antibody screening results among the preoperative examination patients in Beijing Tongren Hospital from 2008 to 2018. Methods: A retrospective analysis of the HIV antibody screening data of thepreoperative examination patients from 2008 to 2018 in Beijing Tongren Hospital was performed with software SPSS19.0. Trend chi-square was used to analyze the positive rate, age, marital status, household registration and so on. Results: Among the 750 013 clinical patients, 428 (0.057%) cases were screened anti-HIV positive and 370(0.049%) cases were confirmed anti-HIV positive when detected with western blotting.Most of the HIV-infectedindividuals were non-Beijing nationality, accounting for 60.27%.Among the 370 HIV-infected patients, there were 334 males (90.27%) and 36 females (9.73%). The age was distributed mainly between 20-40 years old (62.43%), secondly between 40-60 years old (28.65%).361 (97.57%)HIV-infected cases were transmitted by the sex and the MSM men increased from 2008 to 2018 (trend χ²=7.307, P=0.007). There were 22 cases (5.95%) with HBsAg positive, 11 cases (2.97%) with anti-HCV positive. Among the 159 HIV-positive patients (42.97%) companied with syphilis specific antibody positive, there were 64 cases (17.30%) with TRUST tests positive. Additionally, 178 (48.11%) HIV-infected patientsfirst visited doctors because of ocular disease in the hospital; secondly, 71 (19.19%) HIV-infected patientsfirst visited the dermatology. Conclusions: The number of HIV-infected patientsmarkedly increased from 2008 to 2018. The sexual transmission is still the main pathway for HIV infection, particularly homosexual transmission. Moreover, the results indicate that it is necessary to detect HIV antibody for the ocular disease patients.

Down-regulation of miR-192 protects against rat ischemia-reperfusion injury after myocardial infarction.

OBJECTIVE: DJ-1-phosphate and tension homology deleted on chromosome ten/phosphatidylinositol-3-kinase/protein kinase B (PTEN/PI3K/AKT) signaling pathway plays a role in the regulation of ischemic reperfusion (I-R) injury. Bioinformatics analysis demonstrated that there is a complementary binding site between microRNA-192 (miR-192) and the 3'-UTR of DJ-1 mRNA. This study investigated the role of miR-192 in regulating DJ-1-PTEN/PI3K/AKT signaling pathway and myocardial I-R injury. MATERIALS AND METHODS: miR-122 and DJ-1 mRNA expressions in myocardial tissue were detected by Real-time PCR (RT-PCR). DJ-1, PTEN, and phosphorylated AKT (p-AKT) protein expressions were tested by Western blot. Reactive oxygen species (ROS) content was measured by flow cytometry. Malondialdehyde (MDA) content and superoxide dismutase (SOD) enzyme activity were detected by the kits. I-R treatment was performed at 72 h after transfection. Cell apoptosis was evaluated with flow cytometry. RESULTS: Compared with sham group, miR-192, PTEN expressions and MDA content were significantly increased (p<0.05), while DJ-1, p-AKT levels and SOD activities were significantly reduced (p<0.05) in myocardial tissue of I-R group. Compared with control, I-R treatment significantly up-regulated miR-192 level, significantly decreased DJ-1 and p-AKT proteins, significantly elevated PTEN expression, and significantly induced apoptosis and ROS production in H9C2 cells (p<0.05). Transfection of miR-192 inhibitor significantly enhanced DJ-1 level, declined PTEN expression, elevated p-AKT level, and restrained apoptosis, ROS production and MDA content, and promoted SOD activity in H9C2 cells under I-R condition. CONCLUSIONS: The expression of miR-192 increased significantly, while the expression of DJ-1 reduced obviously during I-R injury after myocardial infarction. Down-regulation of miR-192 markedly enhanced DJ-1 expression and PTEN/PI3K/AKT pathway activity, inhibited cell apoptosis and ROS generation, and reduced I-R injury in cardiomyocytes.

Silibinin alleviates inflammation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes and has a therapeutic effect on arthritis in rats.

Silibinin, a natural polyphenolic flavonoid, possesses anti-oxidant, anti-inflammation and anti-cancer properties. The present study was designed to investigate the effects of silibinin on rheumatoid arthritis (RA) pathogenesis-related cells and collagen-induced arthritis (CIA) and further explore the potential underlying mechanisms. Our results showed that silibinin suppressed cell viability and increased the percentage of apoptotic RA-fibroblast-like synoviocytes (FLS). Furthermore, the production of inflammatory cytokines in RA-FLS and a CIA rat model was effectively inhibited by silibinin. Silibinin also induced macrophage M2 polarization in RAW264.7 cells. We further demonstrated that silibinin inhibits Th17 cell differentiation in vitro. The nuclear factor kappa B (NF-κB) pathway was suppressed in RA-FLS. In addition, Sirtuin1 (SIRT1) was decreased after silibinin treatment, and RA-FLS transfection with a short hairpin RNA (shRNA) of SIRT1 enhanced silibinin-induced apoptosis. Autophagy was markedly decreased in a dose-dependent manner following silibinin treatment. These findings indicate that silibinin inhibited inflammation by inhibiting the NF-κB pathway, and SIRT1 may participate in silibinin-induced apoptosis. Silibinin also inhibited autophagy in RA-FLS. Thus, silibinin may be a potential therapeutic agent for the treatment of RA.

Interventional endoscopic treatment of upper gastrointestinal bleeding--when, how, and how often.

Acute upper gastrointestinal (GI) bleeding is still associated with high mortality. Reducing the rebleeding rate is the major challenge in therapeutic endoscopy. The following article describes the indications, techniques and limitations of endoscopic treatment of upper GI bleeding. Endoscopic techniques such as endoscopic sclerotherapy (EIS), endoscopic variceal ligation (EVL), cyanoacrylate obliteration, argon plasma coagulation (APC), and the application of hemoclip are described and compared concerning their efficacy. The pros and cons of "second-look" endoscopy are discussed.